MedPath

Anticoagulant Sodium Citrate

Anticoagulant Sodium Citrate Solution, USPCode 798-60

Approved
Approval ID

3a8dfcfa-e034-40ca-a71f-05099015f87d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 20, 2011

Manufacturers
FDA

Medsep Corporation

DUNS: 928224765

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium Citrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62646-798
Application NumberNDA760305
Product Classification
M
Marketing Category
C73594
G
Generic Name
Sodium Citrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 20, 2011
FDA Product Classification

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATEActive
Quantity: 10 g in 250 mL
Code: 1Q73Q2JULR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Anticoagulant Sodium Citrate - FDA Drug Approval Details